SPATA5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.449600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.589210E-01
Normal-vs-Stage2
5.570200E-01
Normal-vs-Stage3
8.068200E-01
Normal-vs-Stage4
2.082400E-01
Stage1-vs-Stage2
5.703600E-01
Stage1-vs-Stage3
7.938200E-01
Stage1-vs-Stage4
4.612200E-01
Stage2-vs-Stage3
9.679400E-01
Stage2-vs-Stage4
2.691000E-01
Stage3-vs-Stage4
5.866800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.277600E-01
Normal-vs-AfricanAmerican
4.668800E-01
Normal-vs-Asian
7.654400E-01
Caucasian-vs-AfricanAmerican
4.811000E-01
Caucasian-vs-Asian
9.159600E-02
AfricanAmerican-vs-Asian
1.395580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.694200E-01
Normal-vs-Female
5.193200E-01
Male-vs-Female
9.794000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.624200E-01
Normal-vs-Age(41-60Yrs)
3.842800E-01
Normal-vs-Age(61-80Yrs)
6.751000E-01
Normal-vs-Age(81-100Yrs)
4.516000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.577000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.457600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.584000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.139800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.937200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.714000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.247000E-01
Normal-vs-Daily Drinker
5.522800E-01
Normal-vs-Weekly Drinker
9.266200E-01
Normal-vs-Occasional Drinker
5.563600E-01
Normal-vs-Social Drinker
3.155000E-01
Non Drinker-vs-Daily Drinker
7.502600E-01
Non Drinker-vs-Weekly Drinker
4.545200E-01
Non Drinker-vs-Occasional Drinker
6.114600E-01
Non Drinker-vs-Social Drinker
1.476230E-01
Daily Drinker-vs-Weekly Drinker
3.456000E-01
Daily Drinker-vs-Occasional Drinker
8.342800E-01
Daily Drinker-vs-Social Drinker
2.827200E-01
Weekly Drinker-vs-Occasional Drinker
3.239200E-01
Weekly Drinker-vs-Social Drinker
8.357900E-02
Occasional Drinker-vs-Social Drinker
4.494200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.889640E-01
Normal-vs-Grade 2
4.878100E-02
Normal-vs-Grade 3
4.568400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.596350E-02
Grade 1-vs-Grade 3
7.696100E-03
Grade 1-vs-Grade 4
1.889640E-01
Grade 2-vs-Grade 3
4.295400E-01
Grade 2-vs-Grade 4
4.878100E-02
Grade 3-vs-Grade 4
4.568400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.097400E-01
Normal-vs-NonDiabetic
5.631400E-01
Diabetic-vs-NonDiabetic
8.536800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.548850E-01
Normal-vs-NoPancreatitis
5.871000E-01
Pancreatitis-vs-NoPancreatitis
3.703000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.739600E-01
Normal-vs-N1
5.536600E-01
N0-vs-N1
3.127600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.746000E-01
Normal-vs-TP53-NonMutant
4.676400E-01
TP53-Mutant-vs-TP53-NonMutant
1.030630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
